Abu Dhabi — January 26, 2026 — Researchers are edging closer to a future where cancer treatment is as precise as a guided missile, and far less collateral damage. A new nanotechnology, developed at NYU Abu Dhabi, uses light to target and destroy cancer cells with unprecedented accuracy, potentially minimizing the harsh side effects of traditional therapies.
Light-Activated Nanoparticles Offer Hope for More Targeted Cancer Care
A novel approach combines targeted drug delivery with real-time imaging for safer, more effective cancer treatment.
- The technology utilizes biocompatible nanoparticles activated by near-infrared light.
- These particles selectively heat and destroy tumor tissue while sparing healthy cells.
- The system allows for both treatment and real-time monitoring of effectiveness.
- Nanoparticles are designed to accumulate in tumors and avoid immune detection.
Q: How does this new nanotechnology differ from existing cancer treatments?
A: Unlike chemotherapy and radiation, which affect both cancerous and healthy cells, this approach focuses light-activated nanoparticles directly on tumors, minimizing damage to surrounding tissue and offering a potentially less toxic treatment option.
The study, recently published in Cell Reports, builds on the field of photothermal therapy, which harnesses the power of light to generate heat and eliminate cancer cells. The NYU Abu Dhabi team tackled a major hurdle in this area: ensuring the light-responsive materials remain stable within the body and effectively reach the tumor site.
Their solution? Tiny nanoparticles crafted from hydroxyapatite—a mineral naturally found in bones and teeth—coated with lipids and polymers. This design allows the particles to circulate longer in the bloodstream, evading the body’s immune defenses and maximizing delivery to the intended target. The particles are also engineered to exploit the unique characteristics of the tumor environment.
Researchers found the nanoparticles demonstrated high stability, protecting their therapeutic payload from degradation and accumulating efficiently within tumors. Once activated by near-infrared light—chosen for its deeper penetration into the body compared to visible light—the particles generate localized heat, destroying tumor tissue. Crucially, this process also produces fluorescent and thermal signals, enabling doctors to visualize tumors and monitor treatment progress in real time.
“This work brings together targeted treatment and imaging in a single, biocompatible and biodegradable system,” said Mazin Magzoub, senior author of the study and associate professor of biology at NYU Abu Dhabi. “By addressing key challenges in delivering therapeutic agents to tumors, our approach has the potential to improve cancer treatment precision.”
The findings underscore the potential of this nanoparticle system as an integrated tool for both cancer diagnosis and therapy, representing a significant step toward safer and more effective light-based cancer treatments.
